Mabpharm (2181.HK)

Mabpharm share price today, ATLAS forecast and fair value

Healthcare · Biotechnology · Hong Kong Exchanges (HKEX) · Hong Kong SAR China

HK$0.435▼ -1.14%

Prices as of Oct 27, 2026 · HKD

ATLAS fair value

HK$0.383

Above fair value · 14% premium

Range: HK$0.257–HK$0.570Fair valuePrice

Chance of rising in 1 month

46%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Mabpharm in ATLAS

ATLAS's own quantitative analysis, all in one place.

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.

See everything included

Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

On Mabpharm

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.

And for you

ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

Get started →

Plans from €3.99 a month.

ATLAS estimates Mabpharm's fair value at about HK$0.383 per share (reasonable range: HK$0.257 to HK$0.570). At HK$0.435, the stock trades 14% above it.

It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.

ATLAS's model gives Mabpharm a 46% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between HK$0.371 and HK$0.489; in 9 out of 10, between HK$0.291 and HK$0.624. Estimated annual volatility is 80%.

Price, last 12 months (weekly close)

Key numbers

Market cap: HK$2.1B
Market cap (USD): $263M
P/E ratio: 25.0
52-week high: HK$0.810
52-week low: HK$0.310
Revenue (12 months): CN¥770M
Gross margin: 90.1%
Operating margin: 8.5%
Net margin: 11.1%
Beta: 0.60

What this means

These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Mabpharm sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.

Over the last 52 weeks 2181.HK has traded between HK$0.310 and HK$0.810. Today it is 46.3% below that high and 40% above its low.

On the business: net margin is 11.1%; it trades at 25.0 times earnings.

Its beta is 0.60: it tends to move less than the market.

About the company

Mabpharm Limited, a biopharmaceutical company, engages in research, development, production, and commercialization of drugs and biosimilar for cancers and autoimmune diseases in the People's Republic of China.

Want to see everything about Mabpharm?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What is Mabpharm (2181.HK) fair value?

About HK$0.383 per share according to ATLAS (reasonable range: HK$0.257 to HK$0.570). With the stock at HK$0.435, it is 14% above it.

What is the chance 2181.HK goes up next month?

46%: close to a coin flip. In half of the simulated outcomes, 2181.HK ends the month between HK$0.371 and HK$0.489.

How big is Mabpharm and what is its P/E ratio?

Mabpharm's market capitalization is HK$2.1B. Its price-to-earnings (P/E) ratio is 25.0: you pay HK$25.0 for each HK$1.00 of yearly earnings.

How volatile is 2181.HK?

ATLAS estimates annual volatility at 80%. In a typical month, half of the outcomes end between HK$0.371 and HK$0.489.

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer